Stylus Medicine
PrivateLast Round
Series A
Extension
May 13, 2025
Total Funding Raised
$170M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stylus Medicine operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A Extension round in May 2025.
Stylus Medicine is a biotechnology company developing in vivo genetic medicines using engineered recombinase technology and targeted lipid nanoparticle delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stylus Medicine Comparables
Compare Stylus Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoCell Therapeutics | 90% | |
| CREATE Medicines | 88% | |
| Aera Therapeutics | 88% |
For institutional investors. Book with your work email.
Stylus Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 13, 2025 | ||||
| Series A | May 12, 2025 |
For institutional investors. Book with your work email.
Stylus Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A, Series A Extension |
| Khosla Ventures | Series A Extension, Series A |
| Chugai Venture Fund | Series A, Series A Extension |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A, Series A Extension |
| Tachyon Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 660% MoM, reaching 4.7K.
- May 13, 2025
$45M round led by RA Capital Management.
For institutional investors. Book with your work email.
Stylus Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stylus Medicine's valuation, stock price, and market status.
Is Stylus Medicine a public or private company?
Stylus Medicine is a private company.
What is the current stock price of Stylus Medicine?
Stylus Medicine is a private company, so its shares have no public market price. Caplight tracks Stylus Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stylus Medicine worth (valuation)?
Valuation information for Stylus Medicine is not publicly available.
Can I buy Stylus Medicine stock?
Stylus Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stylus Medicine's last funding round?
Stylus Medicine's most recent funding round was Series A Extension on May 13, 2025.
Who are the main investors in Stylus Medicine?
Key investors in Stylus Medicine include RA Capital Management, Khosla Ventures.
Will Stylus Medicine IPO soon?
No public IPO plans have been announced for Stylus Medicine.
How can I track Stylus Medicine secondary market activity?
Caplight tracks bids, offers, and trades in Stylus Medicine's shares on secondary markets.